General presentation of Teva
Now we're going to give you a chance to learn more about Teva by exploring its core business and learning about its biggest sources of revenue.
Teva Pharmaceutical Industries is an Israeli pharmaceutical company. It is also a leader in the development, production and sale of generic pharmaceutical products.
To better understand the Teva Group's activities, they can be divided into different segments according to the share of sales they generate and in this way:
- Generic drugs account for 51.6% of the group's sales, with drugs for the treatment of multiple sclerosis, Parkinson's disease and immune disorders.
- Branded products account for 35.4% of the company's sales, with treatments for central nervous system disorders accounting for 67.9%, respiratory diseases for 13.5%, urogenital and hormonal disorders for 6.7%, cancers and immune disorders for 4.1%, and other diseases such as infections, muscular and orthopaedic problems.
- Organic fine chemicals represent 4.1% of the turnover with active ingredients for the production of medicines.
- Finally, the remaining 8.9% of the company's turnover comes from other types of products including OTC products.
As regards the geographical distribution of the group's activities, 48.1% of its sales are generated in the USA, 30.9% in Europe and 21% in the rest of the world.
79% of retail CFD accounts lose money. This is an advert for trading CFDs on eToro